Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis

Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas

(2012) H. H. Yoon et al.   CLINICAL CANCER RESEARCH

Increasing incidence of Barrett’s oesophagus: a population-based study

(2011) Helen G. Coleman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation

(2011) Rupert Langer et al.   MODERN PATHOLOGY

Incidence of Adenocarcinoma among Patients with Barrett's Esophagus

(2011) Frederik Hvid-Jensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus

(2010) David H. Ilson et al.   CANCER

A 4-Gene Signature Predicts Survival of Patients With Resected Adenocarcinoma of the Esophagus, Junction, and Gastric Cardia

(2010) Christopher J. Peters et al.   GASTROENTEROLOGY

Homogeneous EGFR amplification defines a subset of aggressive Barrett’s adenocarcinomas with poor prognosis

(2010) Andreas H Marx et al.   HISTOPATHOLOGY

Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)

(2010) Philip J. Gold et al.   Journal of Thoracic Oncology

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

(2009) Marjolein Sikkema et al.   Clinical Gastroenterology and Hepatology

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

(2009) M Varella-Garcia et al.   JOURNAL OF CLINICAL PATHOLOGY

Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales

(2008) Côme Lepage et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis

(2008) Neil P. Shah et al.   CANCER CELL

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

(2008) Dana M. Brantley-Sieders et al.   JOURNAL OF CLINICAL INVESTIGATION

Comparative lesion sequencing provides insights into tumor evolution

(2008) S. Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA